Viewing Study NCT01714193


Ignite Creation Date: 2025-12-25 @ 1:23 AM
Ignite Modification Date: 2026-01-01 @ 8:02 AM
Study NCT ID: NCT01714193
Status: COMPLETED
Last Update Posted: 2012-11-19
First Post: 2012-10-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Assess the Effects of Canagliflozin (JNJ-28431754) on the Pharmacokinetics and Safety of an Oral Contraceptive in Healthy Volunteers
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module